STE vs VIR · P/E 25, rev $5.46B vs rev $74.2M
STERIS plc (STE) versus Vir Biotechnology Inc (VIR) — a side-by-side from cached financials, not a winner call.
STERIS plc (STE) is a medical devices company listed on NYSE.
Vir Biotechnology Inc (VIR) is a biotechnology company listed on NASDAQ.
Latest reported STE revenue for 2025-03-31 was $5.46B. Net income was $616.1M. Revenue was up 284.6% from 2024-03-31 to 2025-03-31. STE currently screens at market cap $19.43B and trailing P/E 25.1.
Latest reported VIR revenue for 2024-12-31 was $74.2M. Net income was -$522.0M. Revenue was down 13.9% from 2023-12-31 to 2024-12-31. VIR currently screens at market cap $1.45B.
STE currently screens at market cap $19.43B and trailing P/E 25.1. VIR currently screens at market cap $1.45B.
Not investment advice. Open the STE and VIR stock pages for the full models.
Not investment advice.